Changes in local left and right ventricular myocardial contractility in patients with recurrent atrial fibrillation
Abstract
Aim. To evaluate local contractility of left and right ventricular (LV, RV) myocardium, as well as its dynamics in acute drug test (AMT) with nitroglycerin (NG) in patients with recurrent atrial fibrillation (AF), during sinus rhythm maintenance period. Material and methods. The study included 120 patients aged 39-82 years (mean age 61.3±8.9 years): 20 patients with recurrent AF and arterial hypertension (AH) (Group IA); 50 patients with coronary heart disease (CHD) and recurrent AF (Group IB); 50 individuals from control group (Group II). To assess inotropic myocardial function, balanced radionuclide ventriculography was performed in all participants. Local LV and RV contractility was studied in unified 16-segment ventricular model. After registering baseline hemodynamic parameters, local contractility was assessed again in ADT with NG – 30 minutes after sublingual NG administration (0.5-1.0 mg). Results. In Groups IA and IB, local hypo- and akinesis were observed. In ADT with NG, patients from Groups IA and IB demonstrated improved local contractility: akinetic segment number significantly reduced, normokinetic LV and RV zone number substantially increased. In Group II, during ADT with NG, local contractility increased due to hypokinetic segments. Conclusion. Local contractility disturbances in patients with recurrent AF during sinus rhythm maintenance were manifested as hypo- and akinetic zones. In ADT with NG, patients demonstrated significant improvement of local contractility, due to decreased number of akinetic segments. In control group, number of hypokinetic segments significantly decreased.
About the Authors
I. G. FominaRussian Federation
N. E. Gaidamakina
Russian Federation
A. I. Tarzimanova
Russian Federation
References
1. Авдиенко Л.Н., Малахов В.И., Соколов С.Ф. Ингибиторы АПФ и антагонисты к рецепторам ангиотензина II. Новое направление в лечении мерцательной аритмии? Практик врач 2002; 2: 7-9.
2. Татарский Б.А. Бессимптомная форма фибрилляции предсердий. Серд недостат 2001; 2(5): 21-5.
3. Фомина И.Г., Ветлужский А.В. Существует ли оптимальная стратегия лечения рецидивирующей мерцательной аритмии. Кардиоваск тер профил 2003; 3: 78-90.
4. Ausma J, Wijiffels M, Thone F. Structal changes of atrial myocardium due to sustained atrial fibrillation in goat. Circulation 1997; 96: 3157-63.
5. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-4.
6. Fuster V, Ryden LE, Asinger RW. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). Eur Heart J; 2001: 22: 1852-923.
7. Go AS, Hylek EM, Phillips KA, Chang YuChiao et al. Prevalence of Diagnosed Atrial Fibrillation in Adults. National Implications for Rhythm management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5.
8. Keiny JR, Sacrez A, Facello A Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J 1992; 13: 1290-5.
9. Tsang TS, Gersh BJ, Appleton CP, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. JACC 2002; 40(9): 1636-44.
10. Wolf PA. Abbott RD. Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 1987; 147: 1561-4.
Review
For citations:
Fomina I.G., Gaidamakina N.E., Tarzimanova A.I. Changes in local left and right ventricular myocardial contractility in patients with recurrent atrial fibrillation. Cardiovascular Therapy and Prevention. 2006;5(2):57-63. (In Russ.)